Location: San Francisco, CA
CIK: 0001977548 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value: $298M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| ARGX | ARGENX SE | 150,000 | $111M | 37.1% | $464.20 | — | SPONSORED ADR | 04016X101 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 763,707 | $77.13M | 25.8% | $42.66 | +117.6% | COM | 76243J105 |
| CORT | CORCEPT THERAPEUTICS INC | 392,331 | $32.61M | 10.9% | $72.34 | +0.0% | COM | 218352102 |
| IRON | DISC MEDICINE INC | 430,000 | $28.41M | 9.5% | $56.97 | +4.4% | COM | 254604101 |
| RVMD | REVOLUTION MEDICINES INC | 492,300 | $22.99M | 7.7% | $42.98 | -8.9% | COM | 76155X100 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 260,000 | $10.83M | 3.6% | $31.97 | 0.0% | COM | 22663K107 |
| SEPN | SEPTERNA INC | 283,158 | $5.326M | 1.8% | $11.42 | +14.9% | COM | 81734D104 |
| STOK | STOKE THERAPEUTICS INC | 212,049 | $4.983M | 1.7% | $17.13 | 0.0% | COM | 86150R107 |
| KYMR | KYMERA THERAPEUTICS INC | 61,750 | $3.495M | 1.2% | $41.40 | +8.9% | COM | 501575104 |
| CYTK | CYTOKINETICS INC | 37,587 | $2.066M | 0.7% | $41.20 | 0.0% | COM NEW | 23282W605 |